JUN and neoplasm: Maybe they are competing for binding to the AP-1 sites or by forming “inactive” heterodimers when they are all at high expression15, 39 and the cellular biological process of c-Jun and Fra-1 are complex, they may be also influenced by tumor or tissue types20, 48, 49.